Avandia Manufacturer Failed to Provide Data
On April 8, 2008, the FDA publicized in a warning to GlaxoSmithKline that the company was unsuccessful in reporting all of the required post-approval data on its widely prescribed diabetes drug Avandia. A strong warning about heart attack risk was added to the label of Avandia in November 2007, and ...
